Literature DB >> 17151335

Membrane targeting and secretion of mutant uromodulin in familial juvenile hyperuricemic nephropathy.

Paul Jennings1, Sonia Aydin, Peter Kotanko, Judith Lechner, Karl Lhotta, Sian Williams, Rajesh V Thakker, Walter Pfaller.   

Abstract

Familial juvenile hyperuricemic nephropathy (FJHN) is an autosomal dominant genetic disorder that is characterized by hyperuricemia, gout, and tubulointerstitial nephritis. FJHN is caused by mutations in the UMOD gene, which encodes for uromodulin, the most abundant urinary protein. Herein is demonstrated that patients with FJHN and renal insufficiency exhibit a profound reduction in urinary uromodulin together with either elevated or decreased plasma uromodulin. One young patient with FJHN, however, had normal serum creatinine and normal urinary uromodulin with elevated plasma uromodulin. These observations suggest that there are different urinary and plasma uromodulin profiles in early and late disease and that there may be an altered direction of uromodulin secretion in the course of FJHN as a result of improper intracellular sorting of the mutated protein in the thick ascending limb. With the use of immunohistochemistry and a quantitative immunoassay, targeting and secretion of wild-type and mutant (C77Y and N128S) uromodulin were investigated in the polarized renal epithelial cell line LLC-PK1. In transfected cells, uromodulin mutants were targeted properly to the apical membrane but were secreted less efficiently to the apical compartment than wild-type protein. The expression of mutant uromodulin had no effect on caspase 3 activity. These results indicate that the mutations studied do not impair glycosyl-phosphatidylinositol-mediated apical targeting of the protein but do affect apical secretion. Because the mutant proteins are secreted as efficiently as wild type to the basolateral compartment, the possibility arises that interactions with the immune system at the site of secretion are a contributing factor to the development of tubulointerstitial nephritis in FJHN.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151335     DOI: 10.1681/ASN.2006020158

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  29 in total

Review 1.  Uromodulin in kidney injury: an instigator, bystander, or protector?

Authors:  Tarek M El-Achkar; Xue-Ru Wu
Journal:  Am J Kidney Dis       Date:  2012-01-23       Impact factor: 8.860

2.  Peptidomic Analysis of Urine from Youths with Early Type 1 Diabetes Reveals Novel Bioactivity of Uromodulin Peptides In Vitro.

Authors:  Julie A D Van; Sergi Clotet-Freixas; Joyce Zhou; Ihor Batruch; Chunxiang Sun; Michael Glogauer; Luca Rampoldi; Yesmino Elia; Farid H Mahmud; Etienne Sochett; Eleftherios P Diamandis; James W Scholey; Ana Konvalinka
Journal:  Mol Cell Proteomics       Date:  2019-12-26       Impact factor: 5.911

3.  No amelioration of uromodulin maturation and trafficking defect by sodium 4-phenylbutyrate in vivo: studies in mouse models of uromodulin-associated kidney disease.

Authors:  Elisabeth Kemter; Stefanie Sklenak; Birgit Rathkolb; Martin Hrabě de Angelis; Eckhard Wolf; Bernhard Aigner; Ruediger Wanke
Journal:  J Biol Chem       Date:  2014-02-24       Impact factor: 5.157

4.  Characterization of a recurrent in-frame UMOD indel mutation causing late-onset autosomal dominant end-stage renal failure.

Authors:  Graham D Smith; Caroline Robinson; Andrew P Stewart; Emily L Edwards; Hannah I Karet; Anthony G W Norden; Richard N Sandford; Fiona E Karet Frankl
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 8.237

5.  Autosomal dominant tubulointerstitial kidney disease: a new tool to guide genetic testing.

Authors:  Kaice A LaFavers; Tarek M El-Achkar
Journal:  Kidney Int       Date:  2020-09       Impact factor: 10.612

6.  Molecular and cellular effects of Tamm-Horsfall protein mutations and their rescue by chemical chaperones.

Authors:  Lijie Ma; Yan Liu; Tarek M El-Achkar; Xue-Ru Wu
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

7.  Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations.

Authors:  Guillaume Bollée; Karin Dahan; Martin Flamant; Vincent Morinière; Audrey Pawtowski; Laurence Heidet; Didier Lacombe; Olivier Devuyst; Yves Pirson; Corinne Antignac; Bertrand Knebelmann
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 8.237

8.  Apoptosis induced by an uromodulin mutant C112Y and its suppression by topiroxostat.

Authors:  Sulistiyati Bayu Utami; Endang Mahati; Peili Li; Nani Maharani; Nobuhito Ikeda; Udin Bahrudin; Chishio Munemura; Makoto Hosoyamada; Yasutaka Yamamoto; Akio Yoshida; Yuji Nakayama; Katsumi Higaki; Eiji Nanba; Haruaki Ninomiya; Yasuaki Shirayoshi; Kimiyoshi Ichida; Kazuhiro Yamamoto; Tatsuo Hosoya; Ichiro Hisatome
Journal:  Clin Exp Nephrol       Date:  2014-09-20       Impact factor: 2.801

Review 9.  Uromodulin: old friend with new roles in health and disease.

Authors:  Franca M Iorember; V Matti Vehaskari
Journal:  Pediatr Nephrol       Date:  2013-07-24       Impact factor: 3.714

10.  The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease.

Authors:  Petra Zürbig; Stéphane Decramer; Mohammed Dakna; Justyna Jantos; David M Good; Joshua J Coon; Flavio Bandin; Harald Mischak; Jean-Loup Bascands; Joost P Schanstra
Journal:  Proteomics       Date:  2009-04       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.